Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: breast cancer

September 9, 2026 Drug delivery / Pharma applications / Uncategorized

Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer

Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential

Continue reading

September 8, 2026 Drug delivery / Pharma applications

REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition

A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYK™ (gedatolisib), developed by Celcuity,

Continue reading

September 30, 2025 Drug delivery / Pharma applications

Metal-Organic Frameworks Nanoparticles in the Diagnosis and Treatment of Breast Cancer

Breast cancer remains the most prevalent malignancy among women and the second leading cause of cancer-related mortality worldwide, primarily attributable

Continue reading

March 31, 2025 Drug delivery / Pharma applications

Aspirin in cancer therapy

Aspirin, a non-steroidal anti-inflammatory drug (NSAID), has garnered significant attention for its anti-cancer potential. This review [1] explores the pharmacological

Continue reading

December 5, 2024 Drug delivery / Pharma applications

Complexation by γ-cyclodextrin as a way of improving anticancer potential of sumanene

Biological applications of sumanene buckybowl molecule have been widely discussed over the years yet remain still unexplored experimentally. On the other hand,

Continue reading

October 17, 2024 Drug delivery / Pharma applications

Cyclodextrin-based formulation boosts in vitro anti-tumor potential and lowers toxicity in zebrafish

Paclitaxel (PCTX) is one of the most prevalently used chemotherapeutic agents. However, its use is currently beset with a host

Continue reading

September 26, 2023 Drug delivery / Pharma applications / Uncategorized

Cytotoxicity of 5-Fluorouracil- Loaded, β-Cyclodextrin-Tethered Metallic Copper Nanoparticles on Triple-Negative Breast Cancer Cells

Metal nanoparticles represent simple nanoscale structures that can be employed in drug delivery. The complication due to multiple elements in

Continue reading

September 15, 2022 Drug delivery / Pharma applications

An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy

Cancer denotes a group of more than a hundred types of diseases characterized by the malignant form of abnormal tissue

Continue reading

Recent Posts

  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD
  • 9th China International Biotechnology Conference & Exhibition (BIOTEC-CHINA 2027)

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (355)
  • CD derivatives (430)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (415)
  • Other industrial use (112)
  • Pharma applications (1,218)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • α-CD as laxative for pets and CD as litter deodorant
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • Cyclodextrins in veterinary medicine (Part 1)
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • 12th World Meeting on Pharmaceutics, Biopharmaceutics & Pharmaceutical Technology
  • Effect of cyclodextrins on the pigment production of Pseudomonas aeruginosa
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...